Summary Surgeons have long been concerned that cancer may be disseminated by shedding of tumour cells into the bloodstream during surgery. Early claims that cancer operations induced an increase in the number of tumour cells shed into the circulation were subsequently discredited, and the issue has remained unresolved. We used immunocytochemistry for cytokeratins to detect tumour cells in effluent blood from breast carcinomas in 18 patients undergoing surgery. Tumour cells were detectable in 6/18 patients during surgery, in only one patient before operation and in none post-operatively (P = 0.025). Circulating cells were associated with vascular invasion within the primary tumour (P = 0.032). No cytokeratin-positive cells were found in blood from ten normal volunteers or four patients undergoing surgery for other breast conditions. These results confirm that cancer surgery in humans results in an increase in the shedding of tumour cells into the circulation. The implications for prognosis and practice should be determined by larger prospective studies.
Blood-borne metastasis is the greatest obstacle to cure in patients with cancer. Metastasis is a complex process by which tumour cells enter blood vessels, circulate and exit the system at distant sites (Hart and Saini, 1992) . Trauma to tumours increases both cell shedding and metastasis in animal models (Tyzzer, 1913; Liotta et al., 1976) , leading to concern that cancer surgery might have similar effects in humans. Early studies of cell shedding in humans were confounded by major sampling and cell identification errors, and a general appreciation of the inadequacy of contemporary techniques led to a decline in interest in the subject (Salsbury, 1975) . In recent years emphasis in metastasis research has shifted to the phenotype of the cancer cell, and a number of enzymatic and adhesion molecules have been implicated in the metastatic process (Fidler, 1991; Hart and Saini, 1992) . The importance of the extent of tumour cell shedding into the bloodstream, and the effects of this on cancer surgery have, by contrast, been neglected. The significance of these factors in determining outcome therefore remains unknown.
Monoclonal antibodies against epithelial-restricted epitopes now permit reliable identification of small numbers of carcinoma cells among large numbers of cells of haemopoetic lineage in the bloodstream and bone marrow (Leather et al., 1993; Pantel et al., 1993 Clinical study Cells were detected in the blood of only one patient before operation, in 6 of 18 during surgery, and in none 24 h after operation (see Table II ; Z = -1.964, 1 d.f., P = 0.025, onetailed). In the one patient with detectable cells preoperatively, the number of cells per ml of blood rose 8-fold during surgery (from seven to a peak of 58 cells ml-1). Four of the six patients with detectable cells during surgery had cells present in all three intraoperative samples: the other two had cells in two and one sample respectively (see Table IV can be made from these data. These are therefore essentially qualitative results, but they clearly show a difference between the prevalence of tumour cells in the effluent blood before and during cancer surgery. More truly quantitative data may be obtained if the yield of the method can be substantially improved, for example by more extensive blood sampling and semiautomated screening of cytospins. The use of effluent blood samples is essential, since mixed venous blood has already passed through a capillary bed since cell shedding, and this leads to either entrapment or death of most tumour cells (Fidler, 1991) .
Two previous studies have reported on intraoperative sampling of effluent venous blood from colon and renal cancers, but neither determined whether surgery had any effect on the rate of cell shedding (Glaves et al., 1988; Leather et al., 1993) . Preliminary results using a polymerase chain reaction (PCR) technique to detect circulating tumour cells were similar to our findings, although fewer patients were studied (Brown et al., 1994) . The association of cell shedding with vascular invasion found in our patients is in accordance with experimental findings in animal models, in which metastatic potential is related both to tumour vascularity and to the number of clumps of cells released (Liotta et al., 1976) . Current surgical opinion assigns little or no importance to cell shedding induced by surgery, but there is little scientific evidence to support this view. Tarin et al. (1984) showed massive autotransfusion of tumour cells in ascitic fluid does not necessarily induce metastasis in patients whose cancers were already very advanced. The metabolic, immunological and growth factor environment experienced by cells shed during surgery from a primary tumour without macroscopic metastases may be very different. Tarin's study does not demonstrate that cell numbers are unimportant, merely that other factors are also influential in determining outcome. Studies of the 'no-touch' surgical technique failed to show any survival benefit, but had ample scope for a type II statistical error (failing to detect a real difference due to lack of power). Surgery suppresses cellular immune function and induces expression of growth factors that may stimulate cell division in micrometastases (Lennard et al., 1985; Fisher et al., 1989; Herlyn et al., 1990; McCarthy et al., 1991 
